Abstract:Circulation Research, Ahead of Print. BACKGROUND:Andersen-Tawil syndrome type 1 is a rare heritable disease caused by mutations in the gene coding the strong inwardly rectifying K+channel Kir2.1. The extracellular Cys (cysteine)122-to-Cys154disulfide bond in the channel structure is crucial for proper folding but has not been associated with correct channel function at the membrane. We evaluated whether a human mutation at the Cys122-to-Cys154disulfide bridge leads to Kir2.1 channel dysfunction and arrhythmias by reorganizing the overall Kir2.1 channel structure and destabilizing its open state.METHODS AND RESULTS:We identified a Kir2.1 loss-of-function Cys122mutation (c.366 A>T; p.Cys122Tyr) in an Andersen-Tawil syndrome type 1 family. We generated a cardiac-specific mouse model expressing the Kir2.1C122Ythat recapitulated the abnormal ECG features of Andersen-Tawil syndrome type 1 independently of sex, including corrected QT prolongation, conduction defects, and increased arrhythmia susceptibility. Isolated Kir2.1C122Ycardiomyocytes showed significantly reduced inwardly rectifier K+(IK1) and inward Na+(INa) current densities independently of normal trafficking to and localization at the sarcolemma and the sarcoplasmic reticulum. However, molecular dynamics predicted that the C122Y mutation provoked a conformational change over the 2000-ns simulation, characterized by a greater loss of hydrogen bonds between Kir2.1 and phosphatidylinositol 4,5-bisphosphate than WT. Therefore, the phosphatidylinositol 4,5-bisphosphate–binding pocket was destabilized, resulting in a lower conductance state compared with WT. Accordingly, on inside-out patch clamping, the C122Y mutation significantly blunted Kir2.1 sensitivity to increasing phosphatidylinositol 4,5-bisphosphate concentrations. In addition, the Kir2.1C122Ymutation resulted in channelosome degradation, demonstrating temporal instability of both Kir2.1 and NaV1.5 proteins.CONCLUSIONS:The extracellular Cys122-to-Cys154disulfide bond in the tridimensional Kir2.1 channel structure is essential for the channel function. We demonstrate that breaking disulfide bonds in the extracellular domain disrupts phosphatidylinositol 4,5-bisphosphate–dependent regulation, leading to channel dysfunction and defects in Kir2.1 energetic stability. The mutation also alters functional expression of the NaV1.5 channel and ultimately leads to conduction disturbances and life-threatening arrhythmia characteristic of Andersen-Tawil syndrome type 1.

A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin–biased signaling

Loss of Luminal Ca 2+ Activation in the Cardiac Ryanodine Receptor is Associated with Ventricular Fibrillation and Sudden Death

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Effects of Calcium-Binding Sites in the S2–S3 Loop on Human and Nematostella Vectensis TRPM2 Channel Gating Processes

Endoplasmic Reticulum Ca2+ Measurements Reveal That the Cardiac Ryanodine Receptor Mutations Linked to Cardiac Arrhythmia and Sudden Death Alter the Threshold for Store-Overload-induced Ca2+ Release.

Evolutionary history of calcium-sensing receptors unveils hyper/hypocalcemia-causing mutations

Homology Modeling Identifies C-Terminal Residues That Contribute to the Ca2+ Sensitivity of A Bkca Channel

Molecular mechanism of a COOH‐terminal gating determinant in the ROMK channel revealed by a Bartter's disease mutation

Autosomal dominant hypocalcemia with a novel <i>CASR</i> mutation: a case study and literature review

New insights into renal calcium-sensing receptor activation

Absence of calcium-sensing receptor basal activity due to inter-subunit disulfide bridges

Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome

Hetero Interaction with an Amino Acid Globally Enhances Cooperative Activation of Casr in Response to Extracellular Signaling

Calcium-Mediated Calpain Activation and Microtubule Dissociation in Cell Model of Hereditary Sensory Neuropathy Type-1 Expressing V144D SPTLC1 Mutation

Abstract 13707: Sodium Channel Blockers Prevent Triggered Activity but Not Abnormal Ca2+ Release in a Knock-in Mouse Model with Ryanodine Receptor Mutation R4496C

Calcium-sensing Receptor Diseases and Their Molecular Pathogenesis

The Arrhythmogenic Calmodulin P.phe142leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor*

Molecular mechanism of hyperactivation conferred by a truncation of TRPA1

Diseases associated with calcium-sensing receptor

Autosomal Dominant Hypocalcemia with a Novel Mutation: a Case Study and Literature Review

Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia